vial of retatrutide Research Peptide for Laboratory Studies Retatrutide research peptide - Form

This structure reduces corporate practice of medicine concerns and separates supplement sales from drug administration

Tirzepatide (sold as Mounjaro and Zepbound) is FDA approved and available now, while Retatrutide remains in Phase 3 trials with expected approval sometime between 2026 and 2027

The IV method ensures better absorption and faster results compared to oral supplements

Tirzepatide : Some patients have experienced up to a 20% reduction in body weight over 88 weeks

We are located at 601A Professional Drive, Suite 370, Lawrenceville, GA 30046

Other studies suggest GLP-1s also provide kidney benefits to people who dont have diabetes